These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 15184287)

  • 1. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
    McMullen JR; Sherwood MC; Tarnavski O; Zhang L; Dorfman AL; Shioi T; Izumo S
    Circulation; 2004 Jun; 109(24):3050-5. PubMed ID: 15184287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
    Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
    J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
    Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
    J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
    Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
    Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
    Rose M; Balakumar P; Singh M
    Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA; O'Connell TD; Gerdes AM
    Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of mammalian target of rapamycin signaling in compensatory renal hypertrophy.
    Chen JK; Chen J; Neilson EG; Harris RC
    J Am Soc Nephrol; 2005 May; 16(5):1384-91. PubMed ID: 15788477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pressure overload causes cardiac hypertrophy in beta1-adrenergic and beta2-adrenergic receptor double knockout mice.
    Palazzesi S; Musumeci M; Catalano L; Patrizio M; Stati T; Michienzi S; Di Certo MG; Mattei E; Vitelli L; Marano G
    J Hypertens; 2006 Mar; 24(3):563-71. PubMed ID: 16467660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice.
    van den Bosch BJ; Lindsey PJ; van den Burg CM; van der Vlies SA; Lips DJ; van der Vusse GJ; Ayoubi TA; Doevendans PA; Smeets HJ
    Genomics; 2006 Oct; 88(4):480-8. PubMed ID: 16781840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice.
    Sakaguchi M; Isono M; Isshiki K; Sugimoto T; Koya D; Kashiwagi A
    Biochem Biophys Res Commun; 2006 Feb; 340(1):296-301. PubMed ID: 16364254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFkappaB activation in vivo.
    Ha T; Li Y; Gao X; McMullen JR; Shioi T; Izumo S; Kelley JL; Zhao A; Haddad GE; Williams DL; Browder IW; Kao RL; Li C
    Free Radic Biol Med; 2005 Dec; 39(12):1570-80. PubMed ID: 16298682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding.
    Kee HJ; Sohn IS; Nam KI; Park JE; Qian YR; Yin Z; Ahn Y; Jeong MH; Bang YJ; Kim N; Kim JK; Kim KK; Epstein JA; Kook H
    Circulation; 2006 Jan; 113(1):51-9. PubMed ID: 16380549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinases (p38 and c-Jun NH2-terminal kinase) are differentially regulated during cardiac volume and pressure overload hypertrophy.
    Sopontammarak S; Aliharoob A; Ocampo C; Arcilla RA; Gupta MP; Gupta M
    Cell Biochem Biophys; 2005; 43(1):61-76. PubMed ID: 16043884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats.
    Sheng R; Gu ZL; Xie ML; Zhou WX; Guo CY
    Acta Pharmacol Sin; 2007 Feb; 28(2):191-201. PubMed ID: 17241521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neostigmine and pilocarpine attenuated tumour necrosis factor alpha expression and cardiac hypertrophy in the heart with pressure overload.
    Freeling J; Wattier K; LaCroix C; Li YF
    Exp Physiol; 2008 Jan; 93(1):75-82. PubMed ID: 17872965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thioredoxin-interacting protein controls cardiac hypertrophy through regulation of thioredoxin activity.
    Yoshioka J; Schulze PC; Cupesi M; Sylvan JD; MacGillivray C; Gannon J; Huang H; Lee RT
    Circulation; 2004 Jun; 109(21):2581-6. PubMed ID: 15123525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
    Khan S; Salloum F; Das A; Xi L; Vetrovec GW; Kukreja RC
    J Mol Cell Cardiol; 2006 Aug; 41(2):256-64. PubMed ID: 16769083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.